REFERENCES
- Lo E H, Dalkara T, Moskowitz M A. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003; 4: 399–415
- Le D A, Wu Y, Huang Z, et al. Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci USA 2002; 99: 15188–15193
- Rideout H J, Stefanis L. Caspase inhibition: a potential therapeutic strategy in neurological diseases. Histol Histopathol 2001; 16: 895–908
- Susin S A, Lorenzo H K, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441–446
- Miramar M D, Costantini P, Ravagnan L, et al. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 2001; 276: 16391–16398
- Klein J A, Longo-Guess C M, Rossmann M P, et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 2002; 419: 367–374
- Cregan S P, Fortin A, MacLaurin J G, et al. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 2002; 158: 507–517
- Culmsee C, Zhu C, Landshamer S, et al. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 2005; 25: 10262–10272
- Arnoult D, Parone P, Martinou J C, et al. Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J Cell Biol 2002; 159: 923–929
- Cregan S P, Dawson V L, Slack R S. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 2004; 23: 2785–2796
- Yu S W, Wang H, Poitras M F, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297: 259–263
- Yu S W, Wang H, Dawson T M, et al. Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol Dis 2003; 14: 303–317
- Virág L, Szabó C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375–429
- Endres M, Wang Z Q, Namura S, et al. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 1997; 17: 1143–1151
- Hong S J, Dawson T M, Dawson V L. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 2004; 25: 259–264
- Alano C C, Swanson R A. Players in the PARP-1 cell-death pathway: JNK1 joins the cast. Trends Biochem Sci 2006; 31: 309–311
- Moubarak R S, Yuste V J, Artus C, et al. Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol 2007; 27: 4844–4862
- Xu X, Chua C C, Kong J, et al. Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem 2007; 103: 2004–2014
- Okuno S, Saito A, Hayashi T, et al. The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J Neurosci 2004; 24: 7879–7887
- Ha H C, Snyder S H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999; 96: 13978–13982
- Kaufmann S H, Desnoyers S, Ottaviano Y, et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976–3985
- Lazebnik Y A, Kaufmann S H, Desnoyers S, et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346–347
- Zong W X, Ditsworth D, Bauer D E, et al. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004; 18: 1272–1282
- Li L Y, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001; 412: 95–99
- Lee B I, Lee D J, Cho K J, et al. Early nuclear translocation of endonuclease G and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Neurosci Lett 2005; 386: 23–27
- Arnoult D, Gaume B, Karbowski M, et al. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 2003; 22: 4385–4399
- Vande Velde C, Cizeau J, Dubik D, et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000; 20: 5454–5468
- Zhang Z, Yang X, Zhang S, et al. BNIP3 upregulation and EndoG translocation in delayed neuronal death in stroke and in hypoxia. Stroke 2007; 38: 1606–1613
- Green D R, Reed J C. Mitochondria and apoptosis. Science 1998; 281: 1309–1312
- Green D R, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305: 626–629
- James D, Parone P A, Terradillos O, et al. Mechanisms of mitochondrial outer membrane permeabilization. Novartis Found Symp 2007; 287: 170–176
- Graham S H, Chen J. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 2001; 21: 99–109
- Kubli D A, Ycaza J E, Gustafsson A B. Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem J 2007; 405: 407–415
- Wyllie A H, Kerr J F, Currie A R. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251–306
- Kerr J F, Wyllie A H, Currie A R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257
- Boujrad H, Gubkina O, Robert N, et al. AIF-mediated programmed necrosis: a highly regulated way to die. Cell Cycle 2007; 6: 2612–2619
- Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1: 112–119
- Nicotera P. Apoptosis and age-related disorders: role of caspase-dependent and caspase-independent pathways. Toxicol Lett 2002; 127: 189–195
- White B C, Sullivan J M, DeGracia D J, et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 2000; 179: 1–33